Immunoassay tests are commonly used to diagnose a whole host of disease / medical conditions. In general the technology behind them relies on the manipulation of magnetic nanoparticles. However laboratory and Point of Care tests generally use optical technology to detect these particles; only around 30% of particles can be detected in this way, severely limiting accuracy.
Where others finish up, we start detecting. To a whole new level of accuracy: The MIDS patented technology not only uses a bespoke optical sensor like other devices, but also utilizes miniaturised, highly sensitive custom built “Hall Effect” magnetic sensors embedded within a test strip as a Lab-On-Chip device. This patented technology can detect extremely low levels (nano-Tesla) of magnetic field disturbance caused by discrete test particles; In simple terms, instead of optically reading “clumps of particles” by standard methods, magnetically identifying the signature of discrete particles is expected to produce a substantially more accurate test result within minutes. A rapid test system that accurately measures troponin I and T and other key cardiac markers is, we believe, a blockbuster technology. It should be a “Must Have” for global diagnostic companies.